Tobacco is known to be the second main cause of deaths around the world. Every year about 5 million people die due to tobacco intake. In simple words, 1 out of 10 adults die because of tobacco.
Tobacco is the single preventable cause of death as against the top five factors for mortality.
AdvertisementGlobally, smoking is an important cause of mortality and morbidity. It is unanimously accepted as the main cause of cardiovascular and metabolic disease. Since the sensitivity to insulin is reduced and insulin resistance is increased by smoking so the risk of cardiovascular disease is also enhanced. Smoking elevates plasma triglycerides, causes hypoglycemia and lowers high-density lipoprotein cholesterol. Researchers have revealed that smoking is often related with rise in risk of Metabolic Syndrome and metabolic anomalies.
Hellas Cena and colleagues conducted a cross-sectional study that was published in BMC, to assess the prevalence of Metabolic Syndrome among smokers.
The scientist enrolled people in age group of 28 to 70 years and who were smoking since last 10 years.
They joined the smoking cessation program held by the Respiratory Pathophysiology Unit of San Matteo Hospital, Pavia, Northern Italy.
The volunteers did not have any history of diabetes or coronary artery disease or heart disease (CVD).
The researchers observed that the occurrence of metabolic syndrome was 53.1 percent of which 44.9 percent were in females and 57.3 percent in males respectively.
Rise in variables such as systolic blood pressure, HDL cholesterol and fasting plasma glucose levels was noted in light and heavy smokers.
Finally the researchers advocated that smokers are predisposed to a high threat of metabolic syndrome. They said that proactive interventions are needed to encourage smokers to quit smoking.
Reference: Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers; Hellas Cena et al; BMC Diabetology and Metabolic Syndrome.